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here is one very consistent line of observations in the
back pain literature: Back pain is extremely common,
it is the biggest cause of disability globally, it affects
all age groups, and most people will experience at least one
episode. Recently, the Lancet Low Back Pain Series Working
Group published a series of three papers with a fervent plea
to identify cost-effective and context-specific strategies for
managing low back pain (LBP). The authors call for a strong
and coordinated political action from international and
national policy makers, including World Health Organiza-
tion (WHO) and research funding agencies. They argue that
these two avenues have the potential to substantially reduce
the burden of LBP throughout the world. The Lancet articles
attracted considerable media attention around the globe.
The reason for this could be that they offer ‘‘dramatic
and disturbing messages about LBP and its management
globally.’’1
A first (disturbing) message concerns the current situation
in low-income and middle-income countries (LMICs). Since
influential book by Waddell ‘‘The back pain revolution,’’2
there has been an prevailing view that LBP does not affect
people or the society in LMIC as much as in the western
world, as people were thought to continue their daily
activities, despite LBP. Things have either changed or we
now have more accurate LBP-figures. Years lived with
disability caused by LBP have increased by more than
50% since 1990, especially in LMICs.3,4 Disability related
to LBP is projected to increase most in LMICs where
resources are limited, access to quality health care is gener-
ally poor, and lifestyle shifts toward more sedentary work.
So, to whatever extent it was not already the case, LBP is
now indeed a global disease.
Second, the articles highlight very eloquently that LBP is
a complex condition with multiple contributors to both the
pain and associated disability, including psychological
factors, social factors, biophysical factors comorbidities,
and pain-processing mechanisms.4 However, intuitively
obvious this multifactorial nature may seem, the reality
is that the evidence for most ‘‘well known’’ risk factors is
not overly convincing. Recently, central pain processing
and modulation has attracted particular attention. The
idea is that in chronic pain, ‘‘normal’’ nociceptive and
sensory input is processed in such a way that it leads to
‘‘exacerbated interpretation’’ in the relevant pain-related
areas in the brain. Indeed, there is evidence at a funda-
mental level suggesting these mechanisms play a role.
However, the clinical implications of these findings are
not so clear yet.
Another (grim) message reflects on the management of
LBP, more specifically, on the massive gap that exists
between evidence-based medicine and the management
delivered in every day care.5 Notwithstanding some minor
differences, there are rather consistent recommendations in
the various evidence-based clinical guidelines internation-
ally. The general message is that the first line of care should
consist of education about the condition and ‘‘simple’’
physical and psychological therapies that keep people active
and enable them to stay at work. But the Lancet articles also
stress that even the management strategies judged effective
draw on limited evidence, which opens the possibility for
health care providers to use various other strategies. Unfor-
tunately, a substantial number of the strategies currently
applied, promoted, and reimbursed in daily practice are
more aggressive treatments of dubious benefit associated
with potential harms. For example, painkillers that have a
limited positive effect, at best, are routinely prescribed for
LBP, with a very little emphasis on interventions that are
(more) evidence-based such as exercises. This touches upon
a very important message of the Lancet articles: Successfully
addressing the numerous problems responsible for the inad-
equate care of back pain will require a coordinated
approach involving all the key stakeholders.6 Two of the
most important points to that respect in this ‘‘call for
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action’’ are therefore focused on the health care and research
system: First, health care funders should stop paying for
ineffective and harmful tests and treatments and commis-
sion research on those that are unproven. Second, new
tests and treatments should not be marketed before they
have been adequately tested for safety, efficacy, and cost-
effectiveness.
It may be obvious that these are challenging issues that
will not happen overnight. Publishing these articles is a
good first step and the authors deserve all praise for the fact
that this is accompanied by a dissemination campaign.
Informing all relevant stakeholders is very important, but
for real change more than simply informing relevant stake-
holders is needed. In a world in which complex organiza-
tional structures and vested interests are dominant, the
challenge now is to transform this ‘‘call for action’’ into
‘‘real change.’’ Whether the Lancet series turns out to be the
flywheel for a substantial change in the care of back pain is
in the future.
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